Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Homann, CN; Wenzel, K; Suppan, K; Ivanic, G; Kriechbaum, N; Crevenna, R; Ott, E.
Sleep attacks in patients taking dopamine agonists: review.
BMJ. 2002; 324(7352):1483-1487
Doi: 10.1136%2Fbmj.324.7352.1483
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Homann Carl
- Co-Autor*innen der Med Uni Graz
- Kriechbaum Norbert
- Ott Erwin
- Suppan Klaudia
- Wenzel Karoline
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVES: To assess the evidence for the existence and prevalence of sleep attacks in patients taking dopamine agonists for Parkinson's disease, the type of drugs implicated, and strategies for prevention and treatment. DESIGN: Review of publications between July 1999 and May 2001 in which sleep attacks or narcoleptic-like attacks were discussed in patients with Parkinson's disease. RESULTS: 124 patients with sleep events were found in 20 publications. Overall, 6.6% of patients taking dopamine agonists who attended movement disorder centres had sleep events. Men were over-represented. Sleep events occurred at both high and low doses of the drugs, with different durations of treatment (0-20 years), and with or without preceding signs of tiredness. Sleep attacks are a class effect, having been found in patients taking the following dopamine agonists: levodopa (monotherapy in 8 patients), ergot agonists (apomorphine in 2 patients, bromocriptine in 13, cabergoline in 1, lisuride or piribedil in 23, pergolide in 5,) and non-ergot agonists (pramipexole in 32, ropinirole in 38). Reports suggest two distinct types of events: those of sudden onset without warning and those of slow onset with prodrome drowsiness. CONCLUSION: Insufficient data are available to provide effective guidelines for prevention and treatment of sleep events in patients taking dopamine agonists for Parkinson's disease. Prospective population based studies are needed to provide this information.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Aged, 80 and over -
- Automobile Driving -
- Dopamine Agonists - adverse effects
- Female - adverse effects
- Humans - adverse effects
- Male - adverse effects
- Middle Aged - adverse effects
- Parkinson Disease - drug therapy
- Prospective Studies - drug therapy
- Retrospective Studies - drug therapy
- Sleep Disorders - chemically induced